RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 129 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,655,952 | +2.4% | 8,451,758 | 0.0% | 14.74% | +14.7% |
| Q2 2023 | $63,134,635 | +12.0% | 8,451,758 | 0.0% | 12.84% | +19.5% |
| Q1 2023 | $56,373,229 | -13.5% | 8,451,758 | 0.0% | 10.75% | -16.4% |
| Q4 2022 | $65,163,057 | -27.5% | 8,451,758 | 0.0% | 12.86% | -20.6% |
| Q3 2022 | $89,927,000 | +30.7% | 8,451,758 | 0.0% | 16.21% | +20.5% |
| Q2 2022 | $68,798,000 | +591.9% | 8,451,758 | +508.5% | 13.46% | +595.4% |
| Q1 2022 | $9,944,000 | -58.2% | 1,388,889 | 0.0% | 1.94% | -57.5% |
| Q4 2021 | $23,792,000 | – | 1,388,889 | – | 4.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |